摘要
目的探讨欣母沛应用于具产后出血高危因素产妇行剖宫产术后出血防治中的临床疗效。方法按入院先后顺序,136例具有剖宫产术后出血潜在因素的高危产妇被随机分为观察和对照两组(n=68)。胎儿娩出后,在静滴缩宫素20 U的基础上,对照组给予宫体注射缩宫素20 U,而观察组宫体注射欣母沛250μg。如宫缩仍不佳则间隔15 min,对照组继续应用缩宫素20 U,而观察组继续应用欣母沛250μg。比较两组术后2、24 h的出血量,产后出血的发生率。结果产后2、24 h的出血量,观察组明显少于对照组;产后出血发生率,观察组也明显低于对照组为,组间比较差异有统计学意义(P<0.05)。结论具剖宫产术后出血高危因素的患者,应用静脉滴注缩宫素的同时宫体注射欣母沛,可预防和治疗产后出血,并具有快速、安全的特点,具有重要临床价值。
Objective To explore the clinical efficacy of hemabate for the prevention of maternal risk factors for postpartum hemorrhage hemorrhage after cesarean section. Methods By order of admission, 136 cases of obstetric indications for cesarean section, a potential risk factor of maternal postpartum hemorrhage were randomly divided into observation and control groups （ n = 68 ）. After the baby was delivered, the intravenous infusion of 20U of oxytocin on the basis of the control group were given oxytoein injections Palace 20 U, the observation group injected Palace Hemabate 250ug. If contractions were still poor, the interval 15 min, the control group continued application of oxytocin 20 U, the observation group to continue to apply Hemabate 250ug. Compare 2,24 h postoperative blood loss, the incidence of postpartum hemorrhage. Results The amount of bleeding postpartum 2,24 h, the observation group was significantly lower than the control group; incidence of postpartum hemorrhage the observation group than in the control group, the difference was statistically significant between groups（ P 〈 0.05 ）. Conclusions With postpartum hemorrhage in patients with risk factors for cesarean delivery, intravenous infusion of oxytocm, while injecting Hemabate, prevention and treatment of postpartum hemorrhage with a fast, safe feature, which has important clinical value.
出处
《齐齐哈尔医学院学报》
2014年第4期486-487,共2页
Journal of Qiqihar Medical University
关键词
欣母沛
缩宫素
剖宫产
产后出血
疗效
Hemabate
Oxytocin
Cesarean section
Postpartum hemorrhage
Effect
